BRCA1 and breast carcinoma: Poor contralateral breast cancer (CBC)-free survival and a prevalence of 14.5% in TNBC patients aged ≤ 60 years were observed, contributing to the update in BRCA1/2 genetic testing guidelines in Korea16.